{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:06:29Z","timestamp":1793142389690,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-024-00747-4","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T05:02:27Z","timestamp":1735275747000},"page":"162-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Generation of a selective senolytic platform using a micelle-encapsulated Sudan Black B conjugated analog"],"prefix":"10.1038","volume":"5","author":[{"given":"Sophia","family":"Magkouta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Veroutis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Papaspyropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Lougiakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natassa","family":"Pippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Havaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Palaiologou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris-Foivos","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kambas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nefeli","family":"Lagopati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Boukos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Pouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Marakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanassios","family":"Kotsinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Evangelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Sampaziotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Tamvakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios","family":"Pispas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Petty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Kotopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9001-4112","authenticated-orcid":false,"given":"Vassilis G.","family":"Gorgoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"747_CR1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"31","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 31, 813\u2013827 (2019).","journal-title":"Cell"},{"key":"747_CR2","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1016\/j.cell.2024.05.059","volume":"187","author":"M Ogrodnik","year":"2024","unstructured":"Ogrodnik, M. et al. Guidelines for minimal information on cellular senescence experimentation in vivo. Cell 187, 4150\u20134175 (2024).","journal-title":"Cell"},{"key":"747_CR3","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1016\/j.molcel.2021.10.017","volume":"81","author":"CP Zampetidis","year":"2021","unstructured":"Zampetidis, C. P. et al. A recurrent chromosomal inversion suffices for driving escape from oncogene-induced senescence via subTAD reorganization. Mol. Cell 81, 4907\u20134923 (2021).","journal-title":"Mol. Cell"},{"key":"747_CR4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature05268","volume":"444","author":"J Bartkova","year":"2006","unstructured":"Bartkova, J. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633\u2013637 (2006).","journal-title":"Nature"},{"key":"747_CR5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.1140735","volume":"319","author":"TD Halazonetis","year":"2008","unstructured":"Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 319, 1352\u20131355 (2008).","journal-title":"Science"},{"key":"747_CR6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/path.6164","volume":"260","author":"K Evangelou","year":"2023","unstructured":"Evangelou, K., Belogiannis, K., Papaspyropoulos, A., Petty, R. & Gorgoulis, V. G. Escape from senescence: molecular basis and therapeutic ramifications. J. Pathol. 260, 649\u2013665 (2023).","journal-title":"J. Pathol."},{"key":"747_CR7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","volume":"7","author":"M Demaria","year":"2017","unstructured":"Demaria, M. et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 7, 165\u2013176 (2017).","journal-title":"Cancer Discov."},{"key":"747_CR8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ncb3378","volume":"18","author":"P Galanos","year":"2016","unstructured":"Galanos, P. et al. Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing. Nat. Cell Biol. 18, 777\u2013789 (2016).","journal-title":"Nat. Cell Biol."},{"key":"747_CR9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.trecan.2020.05.004","volume":"6","author":"B Wang","year":"2020","unstructured":"Wang, B., Kohli, J. & Demaria, M. Senescent cells in cancer therapy: friends or foes? Trends Cancer. 6, 838\u2013857 (2020).","journal-title":"Trends Cancer."},{"key":"747_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.08.006","volume":"193","author":"V Myrianthopoulos","year":"2019","unstructured":"Myrianthopoulos, V. et al. Senescence and senotherapeutics: a new field in cancer therapy. Pharmacol. Ther. 193, 31\u201349 (2019).","journal-title":"Pharmacol. Ther."},{"key":"747_CR11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang, L., Lankhorst, L. & Bernards, R. Exploiting senescence for the treatment of cancer. Nat. Rev. Cancer 22, 340\u2013355 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"747_CR12","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu, Y. et al. The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14, 644\u2013658 (2015).","journal-title":"Aging Cell"},{"key":"747_CR13","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/s41591-022-01923-y","volume":"28","author":"S Chaib","year":"2022","unstructured":"Chaib, S., Tchkonia, T. & Kirkland, J. L. Cellular senescence and senolytics: the path to the clinic. Nat. Med. 28, 1556\u20131568 (2022).","journal-title":"Nat. Med."},{"key":"747_CR14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","volume":"19","author":"CA Schmitt","year":"2022","unstructured":"Schmitt, C. A., Wang, B. & Demaria, M. Senescence and cancer\u2014role and therapeutic opportunities. Nat. Rev. Clin. Oncol. 19, 619\u2013636 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"747_CR15","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41596-021-00505-5","volume":"16","author":"J Kohli","year":"2021","unstructured":"Kohli, J. et al. Algorithmic assessment of cellular senescence in experimental and clinical specimens. Nat. Protoc. 16, 2471\u20132498 (2021).","journal-title":"Nat. Protoc."},{"key":"747_CR16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/joim.13141","volume":"288","author":"JL Kirkland","year":"2020","unstructured":"Kirkland, J. L. & Tchkonia, T. Senolytic drugs: from discovery to translation. J. Intern. Med. 288, 518\u2013536 (2020).","journal-title":"J. Intern. Med."},{"key":"747_CR17","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1016\/j.molcel.2023.09.006","volume":"83","author":"S Magkouta","year":"2023","unstructured":"Magkouta, S. et al. A fluorophore-conjugated reagent enabling rapid detection, isolation and live tracking of senescent cells. Mol. Cell 83, 3558\u20133573 (2023).","journal-title":"Mol. Cell"},{"key":"747_CR18","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100300","volume":"38","author":"N Sachs","year":"2019","unstructured":"Sachs, N. et al. Long-term expanding human airway organoids for disease modeling. EMBO J. 38, e100300 (2019).","journal-title":"EMBO J."},{"key":"747_CR19","first-page":"djv406","volume":"108","author":"AE Vilgelm","year":"2015","unstructured":"Vilgelm, A. E. et al. Connecting the dots: therapy-induced senescence and a tumor-suppressive immune microenvironment. J. Natl Cancer Inst. 108, djv406 (2015).","journal-title":"J. Natl Cancer Inst."},{"key":"747_CR20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1039\/C4SC01768D","volume":"6","author":"NA McGrath","year":"2015","unstructured":"McGrath, N. A., Andersen, K. A., Davis, A. K., Lomax, J. E. & Raines, R. T. Diazo compounds for the bioreversible esterification of proteins. Chem. Sci. 6, 752\u2013755 (2015).","journal-title":"Chem. Sci."},{"key":"747_CR21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/acel.12545","volume":"16","author":"K Evangelou","year":"2017","unstructured":"Evangelou, K. et al. Robust, universal biomarker assay to detect senescent cells in biological specimens. Aging Cell 16, 192\u2013197 (2017).","journal-title":"Aging Cell"},{"key":"747_CR22","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/jps.20542","volume":"95","author":"BM Liederer","year":"2006","unstructured":"Liederer, B. M. & Borchardt, R. T. Enzymes involved in the bioconversion of ester-based prodrugs. J. Pharm. Sci. 95, 1177\u20131195 (2006).","journal-title":"J. Pharm. Sci."},{"key":"747_CR23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jb\/mvae032","volume":"176","author":"S Kawakami","year":"2024","unstructured":"Kawakami, S., Johmura, Y. & Nakanishi, M. Intracellular acidification and glycolysis modulate inflammatory pathway in senescent cells. J. Biochem. 176, 97\u2013108 (2024).","journal-title":"J. Biochem."},{"key":"747_CR24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2217\/17435889.1.3.297","volume":"1","author":"ML Immordino","year":"2006","unstructured":"Immordino, M. L., Dosio, F. & Cattel, L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomedicine 1, 297\u2013315 (2006).","journal-title":"Int. J. Nanomedicine"},{"key":"747_CR25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/10717544.2022.2048132","volume":"29","author":"X Zeng","year":"2022","unstructured":"Zeng, X. et al. Construction of pH-sensitive targeted micelle system co-delivery with curcumin and dasatinib and evaluation of anti-liver cancer. Drug Deliv. 29, 792\u2013806 (2022).","journal-title":"Drug Deliv."},{"key":"747_CR26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-023-01469-6","volume":"8","author":"S Shyam Sunder","year":"2023","unstructured":"Shyam Sunder, S., Sharma, U. C. & Pokharel, S. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management. Signal. Transduct. Target. Ther. 8, 262 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"747_CR27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1590\/S1807-59322011000500026","volume":"66","author":"MC Sena","year":"2011","unstructured":"Sena, M. C. et al. Chronic consumption of distilled sugarcane spirit induces anxiolytic-like effects in mice. Clinics (Sao Paulo) 66, 873\u2013878 (2011).","journal-title":"Clinics (Sao Paulo)"},{"key":"747_CR28","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s43587-021-00121-8","volume":"1","author":"NS Gasek","year":"2021","unstructured":"Gasek, N. S., Kuchel, G. A., Kirkland, J. L. & Xu, M. Strategies for targeting senescent cells in human disease. Nat. Aging 1, 870\u2013879 (2021).","journal-title":"Nat. Aging"},{"key":"747_CR29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1474-9726.2006.00199.x","volume":"5","author":"BY Lee","year":"2006","unstructured":"Lee, B. Y. et al. Senescence-associated \u03b2-galactosidase is lysosomal \u03b2-galactosidase. Aging Cell 5, 187\u2013195 (2006).","journal-title":"Aging Cell"},{"key":"747_CR30","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.3390\/cells9122659","volume":"9","author":"J Adamczyk-Grochala","year":"2020","unstructured":"Adamczyk-Grochala, J. & Lewinska, A. Nano-based theranostic tools for the detection and elimination of senescent cells. Cells 9, 2659 (2020).","journal-title":"Cells"},{"key":"747_CR31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243\u2013278 (2023).","journal-title":"Cell"},{"key":"747_CR32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.tcb.2018.03.003","volume":"28","author":"P Sapieha","year":"2018","unstructured":"Sapieha, P. & Mallette, F. A. Cellular senescence in postmitotic cells: beyond growth arrest. Trends Cell Biol. 28, 595\u2013607 (2018).","journal-title":"Trends Cell Biol."},{"key":"747_CR33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/ars.2020.8048","volume":"34","author":"T von Zglinicki","year":"2021","unstructured":"von Zglinicki, T., Wan, T. & Miwa, S. Senescence in post-mitotic cells: a driver of aging? Antioxid. Redox Signal. 34, 308\u2013323 (2021).","journal-title":"Antioxid. Redox Signal."},{"key":"747_CR34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10600","volume":"479","author":"DJ Baker","year":"2011","unstructured":"Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232\u2013236 (2011).","journal-title":"Nature"},{"key":"747_CR35","doi-asserted-by":"crossref","first-page":"192s","DOI":"10.18433\/jpps28987","volume":"21","author":"Z Binkhathlan","year":"2018","unstructured":"Binkhathlan, Z., Ali, R., Qamar, W. & Lavasanifar, A. Pharmacokinetics of orally administered poly(ethylene oxide)-block-poly(\u03b5-caprolactone) micelles of cyclosporine A in rats: comparison with Neoral\u00ae. J. Pharm. Pharm. Sci. 21, 192s\u2013199s (2018).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"747_CR36","doi-asserted-by":"crossref","unstructured":"Binkhathlan, Z. & Lavasanifar, A. in Nanoarchitectonics in Biomedicine Ch. 15 (ed. Grumezescu, A. M.) 507\u2013546 (William Andrew Publishing, 2019).","DOI":"10.1016\/B978-0-12-816200-2.00017-7"},{"key":"747_CR37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11095-021-02990-5","volume":"38","author":"Z Binkhathlan","year":"2021","unstructured":"Binkhathlan, Z., Ali, R., Qamar, W., Al-Lawati, H. & Lavasanifar, A. Pharmacokinetic and tissue distribution of orally administered cyclosporine A-loaded poly(ethylene oxide)-block-poly(\u03b5-caprolactone) micelles versus Sandimmune\u00ae in rats. Pharm. Res. 38, 51\u201365 (2021).","journal-title":"Pharm. Res."},{"key":"747_CR38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijpharm.2007.06.032","volume":"347","author":"O Molavi","year":"2008","unstructured":"Molavi, O. et al. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. Int. J. Pharm. 347, 118\u2013127 (2008).","journal-title":"Int. J. Pharm."},{"key":"747_CR39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13346-017-0369-4","volume":"7","author":"AH Soleimani","year":"2017","unstructured":"Soleimani, A. H. et al. Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma. Drug Deliv. Transl. Res. 7, 571\u2013581 (2017).","journal-title":"Drug Deliv. Transl. Res."},{"key":"747_CR40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.colsurfb.2015.05.015","volume":"132","author":"SM Garg","year":"2022","unstructured":"Garg, S. M., Vakili, M. R. & Lavasanifar, A. Polymeric micelles based on poly(ethylene oxide) and \u03b1-carbon substituted poly(\u025b-caprolactone): an in vitro study on the effect of core forming block on polymeric micellar stability, biocompatibility, and immunogenicity. Colloids Surf. B Biointerfaces 132, 161\u2013170 (2022).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"747_CR41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10557-020-07075-w","volume":"36","author":"E Dookun","year":"2022","unstructured":"Dookun, E., Passos, J. F., Arthur, H. M. & Richardson, G. D. Therapeutic potential of senolytics in cardiovascular disease. Cardiovasc. Drugs Ther. 36, 187\u2013196 (2022).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"747_CR42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1164\/rccm.201810-1975TR","volume":"200","author":"PJ Barnes","year":"2019","unstructured":"Barnes, P. J., Baker, J. & Donnelly, L. E. Cellular senescence as a mechanism and target in chronic lung diseases. Am. J. Respir. Crit. Care Med. 200, 556\u2013564 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"747_CR43","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3390\/cancers12082134","volume":"12","author":"L Wyld","year":"2020","unstructured":"Wyld, L. et al. Senescence and cancer: a review of clinical implications of senescence and senotherapies. Cancers (Basel) 12, 2134 (2020).","journal-title":"Cancers (Basel)"},{"key":"747_CR44","doi-asserted-by":"crossref","first-page":"955","DOI":"10.18632\/aging.101202","volume":"9","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y. et al. New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging (Albany NY) 9, 955\u2013963 (2017).","journal-title":"Aging (Albany NY)"},{"key":"747_CR45","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1182\/blood-2011-04-347849","volume":"118","author":"SM Schoenwaelder","year":"2011","unstructured":"Schoenwaelder, S. M. et al. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood 118, 1663\u20131674 (2011).","journal-title":"Blood"},{"key":"747_CR46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12943-024-02061-4","volume":"23","author":"A Angelopoulou","year":"2024","unstructured":"Angelopoulou, A. et al. Loss of the tumour suppressor LKB1\/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy. Mol. Cancer 23, 147 (2024).","journal-title":"Mol. Cancer"},{"key":"747_CR47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13046-023-02769-z","volume":"42","author":"I Mourkioti","year":"2023","unstructured":"Mourkioti, I. et al. A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer. J. Exp. Clin. Cancer Res. 42, 187 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"747_CR48","doi-asserted-by":"crossref","first-page":"2030158","DOI":"10.1080\/23723556.2022.2030158","volume":"9","author":"CP Zampetidis","year":"2022","unstructured":"Zampetidis, C. P., Papantonis, A. & Gorgoulis, V. G. Escape from senescence: revisiting cancer therapeutic strategies. Mol. Cell. Oncol. 9, 2030158 (2022).","journal-title":"Mol. Cell. Oncol."},{"key":"747_CR49","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1166\/jnn.2014.8869","volume":"14","author":"N Pippa","year":"2014","unstructured":"Pippa, N., Deli, E., Mentzali, E., Pispas, S. & Demetzos, C. PEO-b-PCL grafted DPPC liposomes: physicochemical characterization and stability studies of novel bio-inspired advanced Drug Delivery nano Systems (aDDnSs). J. Nanosci. Nanotechnol. 14, 5676\u20135681 (2014).","journal-title":"J. Nanosci. Nanotechnol."},{"key":"747_CR50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul, F., Erdfelder, E., Lang, A. G. & Buchner, A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods. 39, 175\u2013191 (2007).","journal-title":"Behav. Res. Methods."},{"key":"747_CR51","volume":"8","author":"MJ Schafer","year":"2017","unstructured":"Schafer, M. J. et al. Cellular senescence mediates fibrotic pulmonary disease. Nat. Commun. 8, 14532 (2017).","journal-title":"Nat. Commun."},{"key":"747_CR52","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25453-2","volume":"12","author":"EJ Novais","year":"2021","unstructured":"Novais, E. J. et al. Long-term treatment with senolytic drugs dasatinib and quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat. Commun. 12, 5213 (2021).","journal-title":"Nat. Commun."},{"key":"747_CR53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/B978-0-12-800173-8.00004-0","volume":"39","author":"HM Korashy","year":"2014","unstructured":"Korashy, H. M., Rahman, A. F. & Kassem, M. G. Dasatinib. Profiles Drug Subst. Excip. Relat. Methodol. 39, 205\u2013237 (2014).","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."}],"updated-by":[{"DOI":"10.1038\/s43587-025-00820-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000}}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00747-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00747-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00747-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T03:21:43Z","timestamp":1738380103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00747-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["747"],"URL":"https:\/\/doi.org\/10.1038\/s43587-024-00747-4","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s43587-025-00820-6","URL":"https:\/\/doi.org\/10.1038\/s43587-025-00820-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Described compounds are in patent pending status: (1) Greek Patent Application No. 20240100309, (2) UK Patent Application No. GB2406749.8 and (3) international Patent Cooperation Treaty filing. Patent competing interests concern N.K. and V.G.G. only. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}